Product image of Imigran (Sumatriptan) supplied by GNH India

Imigran

Active Ingredient:
Sumatriptan
Origin:
EU

Imigran (Sumatriptan)

Sumatriptan, the active ingredient in Imigran, is a Triptan presented as a nasal spray for intranasal use. It provides rapid vasoconstriction of cranial blood vessels and inhibition of pro‑inflammatory neuropeptide release, delivering acute relief of migraine attacks and cluster headache episodes in adult patients.

GNH India supplies Imigran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches that meet EU regulatory standards. Our distribution network provides reliable logistics and documentation for cross‑border procurement.

Manufacturer / TM Owner

Glaxosmithkline Trading Services Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imigran (sumatriptan) acts on the serotonergic pathway to treat acute headache disorders.

  • Migraine: rapid relief of moderate to severe migraine attacks with or without aura.
  • Migraine with aura: alleviates headache and associated neurological symptoms when administered early.
  • Cluster headache: abortive treatment of acute cluster headache episodes, reducing pain intensity.
  • Acute episodic cluster headache: provides prompt symptom control during cluster periods.
  • Acute migraine in adults: effective for single‑episode treatment when other analgesics are insufficient.

How It Works

  • Sumatriptan selectively agonizes 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and trigeminal nerve endings. Activation of 5‑HT1B receptors induces vasoconstriction of dilated cranial arteries, while 5‑HT1D stimulation inhibits release of calcitonin gene‑related peptide and other pro‑inflammatory neuropeptides, reducing neurogenic inflammation and pain transmission associated with migraine and cluster headache.

Side Effects

Sumatriptan nasal spray may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Taste disturbance: altered or unpleasant taste sensation in the mouth.
  • Nasal irritation: burning, stinging or discomfort in the nasal passages.
  • Dizziness: feeling light‑headed or unsteady.
  • Nausea: mild stomach upset or urge to vomit.

Serious or Rare Side Effects

  • Chest pain: sensation of pressure or pain in the chest, indicating possible cardiac effects.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity, or rapid heart rate when combined with serotonergic agents.
  • Severe allergic reaction: rash, swelling, difficulty breathing or anaphylaxis.

Precautions & Warnings

When prescribing Imigran, clinicians should consider several safety precautions to minimize risk.

  • Cardiovascular disease: avoid use in patients with uncontrolled hypertension, coronary artery disease, or history of myocardial infarction.
  • Hemiplegic or basilar migraine: contraindicated due to increased risk of cerebrovascular events.
  • Concomitant serotonergic drugs: caution when combined with SSRIs, SNRIs, or MAO inhibitors because of serotonin syndrome risk.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus; limited data available.
  • Age considerations: safety and efficacy not established in pediatric patients under 18 years.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight, and retain in original packaging.

Avoid Interactions

Sumatriptan may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension and serotonin syndrome.
  • SSRIs/SNRIs: increased potential for serotonin syndrome.
  • Ergotamine derivatives: additive vasoconstrictive effects may cause coronary spasm.
  • Other triptans: combined use can precipitate excessive vasoconstriction.
  • Monoamine oxidase inhibitors: similar to MAO inhibitors, avoid co‑administration.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: may enhance blood‑pressure‑lowering effects; monitor blood pressure.
  • CYP2D6 inhibitors: may increase sumatriptan plasma levels; adjust dose if necessary.

Frequently Asked Questions

Imigran contains sumatriptan and is indicated for the acute treatment of migraine attacks and for aborting episodes of cluster headache in adult patients. It is prescribed when rapid relief of severe headache pain is needed and other analgesics have not provided sufficient benefit.

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This action causes constriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, thereby reducing vascular inflammation and the transmission of pain signals that cause migraine and cluster headache.

The dose of Imigran is determined by the prescribing healthcare professional based on the individual’s clinical condition, severity of the attack, and prior response to therapy. The prescriber will specify the number of nasal sprays to be administered and any limits on repeat dosing within a 24‑hour period.

Safety data for sumatriptan in pregnancy are limited. It should only be used if the potential benefit justifies the potential risk to the fetus. During breastfeeding, the drug is excreted in small amounts in milk; a risk‑benefit assessment should be performed by the prescriber before use.

To order Imigran, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imigran (sumatriptan) belongs to the triptan class, which provides targeted serotonin‑mediated vasoconstriction. Compared with non‑specific analgesics, triptans act faster and are more effective for moderate to severe migraine. Alternative triptans or newer CGRP‑targeted therapies may be chosen based on patient tolerance, cardiovascular risk, and individual response.

Imigran nasal spray should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperatures. Keep the device tightly closed when not in use and keep it out of reach of children.

Imigran is administered intranasally. The patient inserts the spray tip into one nostril, inhales gently, and actuates the device as instructed by the prescriber. Typically a single spray is used for an acute attack, with repeat dosing only after the prescribed interval and under medical guidance.

Serious risks include chest pain or coronary vasospasm, which may signal cardiac ischemia, and serotonin syndrome when combined with other serotonergic agents. Rarely, severe allergic reactions such as anaphylaxis can occur. Patients should seek immediate medical attention if they experience these symptoms.

Imigran is contraindicated in patients with uncontrolled hypertension, known coronary artery disease, a history of myocardial infarction, hemiplegic or basilar migraine, and those taking monoamine oxidase inhibitors within 14 days. It should also be avoided in individuals with known hypersensitivity to sumatriptan or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.